Immunterapi og vaccinationsstrategier ved
behandling af kastrationsresistent metastaserende prostatacancer.
Supervisors: Professor Inge Marie Svane, MD, PhD
Head of Department of Oncology, Lisa Sengeløv, MD, DMSc. Henriette
Lindberg, MD, PhD
Stine
Krogh Frandsen, cand.scient humanbiologi
Calcium
electroporation in cancer treatment: Mechanisms of action, and sensitivity of
malignant and normal tissues.
Suprevisors: Julie
Gehl, MD, PhD
Medvejleder: Professor, overlæge dr. med. Dorte Nielsen
Iben
Kümler, MD
Individualized treatment with irinotecan of
patients with locally advanced or metastatic breast cancer, guided by copy
number of the topoisomerase 1 (TOP1) gene.
Hovedvejledere: Professor, overlæge dr. med.
Dorte Nielsen/professor Nils Brünner
Mogens
Karsbøl Boisen, MD
Discovery of new
microRNA biomarkers for treatment response and prognosis in patients with
colorectal cancer treated with bevacizumab.
Hovedvejleder:
Professor, overlæge dr. med. Julia Sidenius Johansen
Medvejledere:
Seniorforsker og ph.d. Estrid Høgdall og overlæge dr. med. Benny Vittrup Jensen
Rikke
Andersen, MD
Adoptive cell therapy with tumor
infiltrating lymphocytes for patients with melanoma and renal cell carcinoma.
Hovedvejleder: Professor, overlæge ph.d. Inge Marie Svane
Medvejledere: Professor, biolog Per Thor Straten og reservelæge ph.d.
Marco Donia
Camilla
Kjær Lønkvist
Muscle-to-cancer crosstalk in head and
neck cancer patients; the effect of exercise training.
Hovedvejleder: Professor, overlæge dr. med. Dorte
Nielsen
Medvejledere: Overlæge ph.d. Julie Gehl, humanbiolog ph.d.
Pernille Højman, Overlæge Elo Andersen, overfysioterapeut Hanne Forbech
Skall
Troels
Holz Borch, MD
Evaluation of vaccine-specific immune
response in patients with metastatic melanoma or breast cancer treated with
dendritic cells transfected with survivin, hTERT and p53
mRNA.
Hovedvejledere: Professor, overlæge ph.d. Inge Marie Svane og
professor, biolog Per Thor Straten
Medvejleder: Reservelæge ph.d. Marco
Donia
Dan
Taksony Solyom Høgdall
MicroRNA biomarkers in blood for
early detection of cholangiocarcinoma and prediction of prognosis and treatment
response.
Hovedvejleder: Professor, overlæge dr.med. Julia S.
Johansen
Medvejledere: Overlæge ph.d. Ole Larsen og MSc, Ph.d. Jesper
Bøje Andersen fra Biotech Research and Innovation Centre (BRIC)